Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort

Abstract Background The evidence regarding effects of statins on exacerbation risk in COPD remains controversial. Previous studies often excluded patients with cardiovascular comorbidities despite their high prevalence in COPD and role for exacerbations. Based on the cardioprotective properties of s...

Descrizione completa

Dettagli Bibliografici

Autori principali:	N. Frantzi, X. P. Nguyen, C. Herr, P. Alter, S. Söhler, D. Soriano, H. Watz, B. Waschki, F. Trinkmann, M. Eichenlaub, F. C. Trudzinski, J. D. Michels-Zetsche, A. Omlor, F. Seiler, I. Moneke, F. Biertz, G. Rohde, D. Stolz, T. Welte, H. U. Kauczor, K. Kahnert, R. A. Jörres, C. F. Vogelmeier, R. Bals, S. Fähndrich, on behalf of the German COSYCONET Cohort
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2024-05-01
Serie:	Respiratory Research
Soggetti:	Statins COPD Exacerbations Cardiovascular comorbidities
Accesso online:	https://doi.org/10.1186/s12931-024-02822-1
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!